Shanghai Henlius Biotech
1 products tracked · names used in filings: Shanghai Henlius Biotech
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 13 Nov 2025🇺🇸 FDA approval
FDA approves biosimilar Poherdy (pertuzumab-dpzb)
Shanghai Henlius Biotech; BLA761450; Biosimilar; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Poherdy pertuzumab-dpzb | Approved | 2025-11-13 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.